E-LIB Suche - Ergebnisse für: Kao S

1

442P AI routine blood signature as a tumour marker to predi..:

Cheung, K.M. ; Seo, M. ; Lam, S.J.L....
Annals of Oncology. 35 (2024) - p. S177-S178 , 2024

Link: https://doi.org/10.1016/..

2

437P Early gastric cancer detection with AI-enabled routine..:

Seo, M. ; Cheung, K.M. ; Lam, S.J.L....
Annals of Oncology. 35 (2024) - p. S176 , 2024

Link: https://doi.org/10.1016/..

3

DOUBLE FREE FLAPS RECONSTRUCTION FOR EXTENSIVE COMPOSITE DE..:

Kao, T. ; Kao, S.
International Journal of Oral and Maxillofacial Surgery. 52 (2024) - p. 85 , 2024

Link: https://doi.org/10.1016/..

4

Real-world outcomes with durvalumab after chemoradiotherapy..:

Filippi, A.R. ; Bar, J. ; Chouaid, C....
ESMO Open. 9 (2024) 6 - p. 103464 , 2024

Link: https://doi.org/10.1016/..

5

OA04.03 Australian Registry and Biobank of Thoracic Cancers..:

Rogers, J. ; Itchins, M. ; Harden, S....
Journal of Thoracic Oncology. 18 (2023) 11 - p. S51-S52 , 2023

Link: https://doi.org/10.1016/..

6

IMMUNOPATHOLOGY OF DIABETES MELLITUS IN PULMONARY TUBERCULO..:

Thong, P.M. ; Bai, C. ; Loh, F.K....
International Journal of Infectious Diseases. 130 (2023) - p. S7 , 2023

Link: https://doi.org/10.1016/..

7

Factors associated with recurrent appendicitis after succes..:

Flum, David R ; Rosen, J E ; Voldal, E C...
British Journal of Surgery. , 2023

Link: https://doi.org/10.1093/..

8

P2.10-01 ALKTERNATE: A Pilot Study Alternating Lorlatinib w..:

Itchins, M. ; Liang, S. ; Brown, C....
Journal of Thoracic Oncology. 18 (2023) 11 - p. S351-S352 , 2023

Link: https://doi.org/10.1016/..

9

OA03.06 Repotrectinib in Patients with ROS1 Fusion-positive..:

Cho, B.C. ; Camidge, D.R. ; Lin, J.J....
Journal of Thoracic Oncology. 18 (2023) 11 - p. S50-S51 , 2023

Link: https://doi.org/10.1016/..

10

OA01.04 Five-Year Survival in Patients with ES-SCLC Treated..:

Liu, S.V. ; Dziadziuszko, R. ; Sugawara, S....
Journal of Thoracic Oncology. 18 (2023) 11 - p. S44-S45 , 2023

Link: https://doi.org/10.1016/..

11

MA17.05 Real World Outcomes of Immunotherapy (IO) for Pleur..:

McNamee, N. ; Harvey, C. ; Gray, L....
Journal of Thoracic Oncology. 18 (2023) 11 - p. S163 , 2023

Link: https://doi.org/10.1016/..

12

P2.21-02 A Combination of PD-1 and TIGIT Checkpoint Blockad..:

Shi, H. ; Johnson, B. ; Yu, T.-K....
Journal of Thoracic Oncology. 18 (2023) 11 - p. S388 , 2023

Link: https://doi.org/10.1016/..

13

EP16.03-005 Australian Non-Small Cell Lung Cancer (NSCLC) B..:

Gard, G. ; Kao, S. ; Solomon, B....
Journal of Thoracic Oncology. 17 (2022) 9 - p. S587 , 2022

Link: https://doi.org/10.1016/..

14

Squamous cell carcinoma differentiation at progression as a..:

Heynemann, S. ; Prosser, N. ; Lee, J....
Pathology. 54 (2022) 7 - p. 935-938 , 2022

Link: https://doi.org/10.1016/..

15

Pivotal topline data from the phase 1/2 TRIDENT-1 trial of ..:

Cho, B.C. ; Lin, J. ; Camidge, D.R....
European Journal of Cancer. 174 (2022) - p. S1-S2 , 2022

Link: https://doi.org/10.1016/..